One Step Forward, Two Steps Back — Will There Ever Be an AIDS Vaccine?
Open Access
- 27 December 2007
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (26) , 2653-2655
- https://doi.org/10.1056/nejmp0708117
Abstract
In April 1984, when the human immunodeficiency virus (HIV) and AIDS were just beginning to be understood, a senior official in the Department of Health and Human Services stated at a press conference that there would be a marketable vaccine within “a minimum of two years, probably more like three years.”1 This prediction has haunted the search for an AIDS vaccine, whose most recent setback was the announcement that a promising vaccine candidate, Merck's V520, was not effective and may actually have increased some subjects' risk of acquiring HIV. Unfortunately, about a quarter-century after the discovery of HIV, there is neither a marketable vaccine nor a credible expectation about when there will be one.Keywords
This publication has 3 references indexed in Scilit:
- An HIV Vaccine — Evolving ConceptsNew England Journal of Medicine, 2007
- Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, ThailandThe Journal of Infectious Diseases, 2006
- Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 InfectionThe Journal of Infectious Diseases, 2005